David Dodwell

Is age a barrier to chemotherapy? Rates of treatment in older patients with breast, colon or lung cancer in England in 2014: A national registry study.

P. Selby, D. Dodwell, A. Ring, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.

R. Paridaens, M. Carpentieri, C. Snowdon, 2004, The New England journal of medicine.

Response after withdrawal of tamoxifen and progestogens in advanced breast cancer.

A. Howell, D. Dodwell, H. Anderson, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials

R. Gelber, A. Tutt, M. Piccart, 2023, The Lancet.

Postmenopausal advanced breast cancer: options for therapy after tamoxifen and aromatase inhibitors.

S. Johnston, D. Dodwell, A. Wardley, 2006, Breast.

Cognitive ability in childhood and cognitive decline in mid-life: longitudinal birth cohort study

P. Lønning, L. Fallowfield, L. Gibson, 2003, BMJ : British Medical Journal.

Optimum anthracycline-based chemotherapy for early breast cancer.

D. Dodwell, J. Adlard, David Dodwell, 2001, The Lancet. Oncology.

The Lancet Breast Cancer Commission

O. Olopade, R. Jagsi, B. Zikmund‐Fisher, 2024, The Lancet.

Tricks and tips for target volume definition and delineation in breast cancer: lessons learned from ESTRO breast courses.

M. Aznar, D. Dodwell, T. Major, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.